Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine pharmacokinetics during breast reconstruction surgery
ACTRN12623000240640Phase 4Not yet recruiting
- Sponsor
- Royal Perth Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine in pain, sponsored by Royal Perth Hospital. Primary endpoint: Lidocaine pharmacokinetics by serial serum concentration determination. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12623000240640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000240640.